Copyright
©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 101916
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.101916
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.101916
Figure 5 Dl-3-n-butylphthalide reduces cell apoptosis under high glucose conditions.
A: Flow cytometry detection of cell apoptosis of Human umbilical vein endothelial cells; B: Flow cytometry detection of human keratinocytes cells; C: Flow cytometry detection of human dermal fibroblasts; D: Statistical results of apoptotic cells in flow cytometry; E: TUNEL staining was detected the cell apoptosis of human umbilical vein endothelial cells; F: TUNEL staining of human keratinocytes cells; G: TUNEL staining of human dermal fibroblasts; H: Statistical analysis of the percentage of apoptotic cells according to the result of the TUNEL assay; I: Apoptosis-related protein expression was examined by Western blot analysis. Data expressed as individual values with mean ± SD. dP < 0.0001, cP < 0.001, bP < 0.01, aP < 0.05. HG: High glucose; NBP: Dl-3-n-butylphthalide; HUVEC: Human umbilical vein endothelial cells; HaCaT: Human keratinocyte cells; HDF: Human dermal fibroblasts.
- Citation: Wei WH, Bai YL, Zhu D, Zhang JY, Yin QC, Li Q, Shen CQ, Jin PS. Dl-3-n-butylphthalide ameliorates diabetic foot ulcer by inhibiting apoptosis and promoting angiogenesis. World J Diabetes 2025; 16(4): 101916
- URL: https://www.wjgnet.com/1948-9358/full/v16/i4/101916.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i4.101916